Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
09. January 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8754
Articles 1 - 20 / 175071
Machine Learning Integration Framework Constructs a Lactylation-Associated Gene Signature to Improve Prognosis in Bladder Cancer.
Cancer Med
Wang J, Lu Q, Jiao P, Jian J, Zheng Q, Chen Z, Liu X, Wan S, Wang L.
PMID: 41505248 [PubMed - indexed for MEDLINE]
Study on the Role of Long Non-Coding RNA GAS5 in Promoting the Malignant Progression of Prostate Cancer by Regulating miR-12/GPRC5B Signaling Axis.
Bull Exp Biol Med
Li C.
PMID: 41505048 [PubMed - as supplied by publisher]
Non-invasive urine-based detection of PSMA-positive exosomes using a dual-aptamer electrochemical aptasensor for prostate cancer diagnosis.
Mikrochim Acta
Amin-Sadrabadi E, Omidfar K.
PMID: 41505006 [PubMed - in process]
Significance and Implications of Prostate Cancer: Critical Overview for Future Directions in Africa.
Cancer Invest
Gayi BK, Aiduenu AF, Dofuor AK, Tawiah-Nyarko S, Loh SK, Yamoah JAA, Ekloh W, Akomea A, Anovunga SA, Asafu-Adjaye A.
PMID: 41504175 [PubMed - as supplied by publisher]
Influence of androgen deprivation therapy on physical performance and muscle strength in prostate cancer patients - a systematic review.
Rep Pract Oncol Radiother
Szarzy, Barczak I, Giermek K, Garczyk A, Mardas M, Stelmach-Mardas M.
PMID: 41503555 [PubMed]
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review.
Oncol Res
Iovane G, Traman L, Maffezzoli M, Fornarini G, Corradi D, Guareschi D, Santoni M, Buti S.
PMID: 41502513 [PubMed - indexed for MEDLINE]
Development and validation of MRI-based models to predict lymph node metastasis in bladder cancer: a multi-center study.
Cancer Imaging
Bai R, Cai L, Jiang M, Wang C, Tan Z, Zhuang J, Jiang X, Wu Q, Tian W, Wu C, Liu X, Liang B, Cao Q, Yang X, Lu Q.
PMID: 41501950 [PubMed - as supplied by publisher]
Prostate cancer screening and associated factors in Ethiopia: a systematic review and meta-analysis.
BMC Cancer
Ayalew TL, Feleke MG, Ashager K, Eshetu A.
PMID: 41501667 [PubMed - as supplied by publisher]
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.
Prostate Cancer Prostatic Dis
Büttner T, Rizzo M, Bernal Vaca L, Molina-Cerrillo J, Alonso-Gordoa T, Juárez A, Buchler T, Seront E, Kucharz J, Gandur Quiroga MN, Bourlon MT, Bögemann M, Kopecky J, Rescigno P, Fiala O, Rodriguez-Vida A, Myint ZW, Ürün Y, Scagliarini S, Poprach A, Matthews D, Li H, Rizzo A, Mosca A, Lenci E, Melichar B, Wenzel M, Mandell P, Massari F, Antonarakis ES, Santoni M.
PMID: 41501561 [PubMed - as supplied by publisher]
Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort.
Prostate Cancer Prostatic Dis
Mack A, Tran TD, Berglund E, Andriole GL, Alley C, Sisk AE, Estrada-Reyes I, Bissell K, Bellerose H, Jarman A, Hoffmeyer A, Burns M, Sanders S, Vail E, Pao A, Khurram R, Ahmed A, Freedland SJ.
PMID: 41501560 [PubMed - as supplied by publisher]
Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study.
Sci Rep
Wänman J, Farhang M, Nyström H, Styrke J, Häggström C, Stattin P, Crnalic S.
PMID: 41501291 [PubMed - as supplied by publisher]
The Evolution of Prostate Multiparametric MRI and Its Application in Prostate Cancer Clinical Management.
Int J Urol
Tamada T, Takeuchi M, Moriya K, Ueda Y, Yamamoto A, Higaki A.
PMID: 41500965 [PubMed - as supplied by publisher]
Prospective study on tumor control, survival, toxicity and quality of life after EBRT and an HDR-brachytherapy boost in intermediate to high-risk prostate cancer patients.
Brachytherapy
Peters M, Nuver TT, Rasing MJA, Noordhoek MC, Haverkort MAD, Schimmel EC, Schoevers WJ, Czerwinski MD, van Rossum PSN, Kattevilder RAJ, Minken AW.
PMID: 41500898 [PubMed - as supplied by publisher]
Rosai-Dorfman disease mimicking testicular malignancy in a patient with marginal zone lymphoma of the lung.
BMJ Case Rep
Lee-Diaz E, Vaughan VC, Zhang L, Pan Z, La Rosa FG.
PMID: 41500717 [PubMed - indexed for MEDLINE]
The role of focal therapy for localized prostate cancer: From diagnosis to ablation.
Actas Urol Esp (Engl Ed)
Roldán-Testillano R, Rodríguez-Sánchez L, Rodríguez Socarrás ME, de Andrés Boville G, Durazo-Ruiz F, Gómez Rivas J, Alfambra Fernández H, Sánchez Macías J, Bianco FJ, Mińana López B, Sanchez-Salas R.
PMID: 41500454 [PubMed - as supplied by publisher]
Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.
Actas Urol Esp (Engl Ed)
Saouli A, Contieri R, Quhal F, Hurle R, Guenouni M, Ploussard G, Mori K, Yanagisawa T, Pradere B, Laukhtina E, Rajwa P, Albisinni S, Krajewski W, Cimadamore A, Del Giudice F, Gómez Rivas J, Soria F, Shariat SF, Gontero P, Mertens LS, van Rhijn BWG, AlShammari M, Gallioli A, Moschini M.
PMID: 41500450 [PubMed - as supplied by publisher]
Past and present of prostate cancer screening in the european union.
Actas Urol Esp (Engl Ed)
Gómez Rivas J, Gómez Dávila P, Tarrazo Antelo AM, Corujo Quinteiro M, Gómez Amorín Á, Rodríguez Alonso A, Vilaseca JM, López H, Salazar JP, Borque-Fernando Á, Moreno-Sierra J, Collen S, Beyer K, Helleman J, Roobol MJ, van Poppel H, en representación de PRAISE-U Consortium.
PMID: 41500446 [PubMed - as supplied by publisher]
Select updates in the pathology of kidney, testis, and penile cancer for 2026: Including FLCN-mutated (kidney) tumors, paratesticular mesothelial tumors, and TP53/HPV status in penile squamous cell carcinoma.
Hum Pathol
Tekin B, Whaley RD, Collins K, Erickson LA, Cheng L, Gupta S.
PMID: 41500272 [PubMed - as supplied by publisher]
Urinary amino acid profiles emerge as promising biomarkers for predicting and assessing the prognosis of clear cell renal cell carcinoma: a retrospective case-control Study.
Int J Surg
Wang H, Li P, Guo G, Gu L, Zhang X, Zhang F.
PMID: 41499732 [PubMed - as supplied by publisher]
Generative Artificial Intelligence Successfully Automates Data Extraction From Unstructured Magnetic Resonance Imaging Reports: Feasibility in Prostate Cancer Care.
JCO Clin Cancer Inform
Odisho AY, Liu AW, Pace WA, Carlisle MN, Krumm R, Cowan JE, Carroll PR, Cooperberg MR.
PMID: 41499717 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 175071
Page 1 of 8754
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy